CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.

Citation data:

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, ISSN: 1386-6532, Vol: 34, Issue: 4, Page: 302-9

Publication Year:
2005
Usage 32
Abstract Views 31
Link-outs 1
Captures 12
Readers 10
Exports-Saves 2
Citations 12
Citation Indexes 12
Repository URL:
https://ro.uow.edu.au/smhpapers/211
PMID:
16286054
DOI:
10.1016/j.jcv.2004.05.021
Author(s):
Passam, Andreas M; Zafiropoulos, Alexandros; Miyakis, Spyridon; Zagoreos, Ioannis; Stavrianeas, Nikolaos G; Krambovitis, Elias; Spandidos, Demetrios A
Publisher(s):
Elsevier BV
Tags:
Immunology and Microbiology; Medicine; therapy; haart; undergoing; patients; aids; 64i; prognosis; ccr2; favorable; confer; alleles; 3; cxcl12; Medicine and Health Sciences; Social and Behavioral Sciences
article description
The chemokine receptor polymorphisms CCR5Delta32, CXCL12 3'A, CCR2-64I and CCR5-59029 G/A have been demonstrated to affect HIV-1 infection and progression.